Stone X Group Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Stone X Group Inc.

$2.29 Trillion
Q3 2025

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Aug 13, 2025	BUY	$1024.09 - $1201.76 $223,251 - $261,983	218 New	218 $229 Million
Q1 2024 Aug 13, 2025	SELL	$902.69 - $993.35 $37,912 - $41,720	-42 Reduced 15.16%	235 $226 Million
Q4 2023 Aug 13, 2025	BUY	$775.18 - $881.7 $214,724 - $244,230	277 New	277 $243 Million
Q3 2023 Aug 13, 2025	BUY	$692.45 - $844.37 $173,112 - $211,092	250 New	250 $206 Million
Q1 2023 Aug 13, 2025	BUY	$680.49 - $826.97 $227,283 - $276,207	334 New	334 $274 Million

Q1 2022 Aug 13, 2025	BUY	$595.12 - $698.43 $243,999 - $286,356	410 New	410 $286 Million
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $224,360 - $263,308	-377 Closed	0 $0
Q4 2021 Aug 13, 2025	BUY	$543.48 - $670.97 $204,891 - $252,955	377 New	377 $238,000
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $56,521 - $69,780	-104 Reduced 21.62%	377 $238,000
Q3 2021 Oct 20, 2021	SELL	$574.03 - $680.96 $3,444 - $4,085	-6 Reduced 1.23%	481 $291,000
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $4,728 - $5,585	10 Added 2.1%	487 $272,000
Q1 2021 Jun 23, 2021	SELL	$446.73 - $548.2 $14,295 - $17,542	-32 Reduced 6.29%	477 $225,000
Q4 2020 Feb 03, 2021	BUY	$478.3 - $607.98 $2,391 - $3,039	5 Added 0.99%	509 $245,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $12,529 - $15,138	23 Added 4.78%	504 $282,000
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $14,799 - $19,317	-30 Reduced 5.87%	481 $299,000
Q1 2020 Apr 30, 2020	BUY	$336.18 - $494.43 $171,787 - $252,653	511 New	511 $249,000
Q3 2018 Oct 03, 2018	SELL	$351.14 - $408.51 $236,668 - $275,335	-674 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$284.6 - $344.99 $191,820 - $232,523	674 New	674 $233,000
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $303,691 - $354,816	-704 Closed	0 $0
Q2 2017 Aug 31, 2017	BUY	N/A	704	704 $346,000

Others Institutions Holding REGN

# of Institutions

1,483

Shares Held

86.4M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Account